Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19)
Abstract. Objectives:. This study aimed to investigate the effect of the coronavirus disease 2019 (COVID-19) pandemic on the treatment of children with primary monosymptomatic nocturnal enuresis (MNE) with desmopressin melt versus an enuresis alarm. Materials and methods:. This study included 56 chi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health
2022-06-01
|
| Series: | Current Urology |
| Online Access: | http://journals.lww.com/10.1097/CU9.0000000000000126 |
| _version_ | 1797976935200980992 |
|---|---|
| author | Umut Unal Hakan Anil Mehmet Eflatun Deniz Ediz Vuruskan Adem Altunkol Hakan Ercil |
| author_facet | Umut Unal Hakan Anil Mehmet Eflatun Deniz Ediz Vuruskan Adem Altunkol Hakan Ercil |
| author_sort | Umut Unal |
| collection | DOAJ |
| description | Abstract. Objectives:. This study aimed to investigate the effect of the coronavirus disease 2019 (COVID-19) pandemic on the treatment of children with primary monosymptomatic nocturnal enuresis (MNE) with desmopressin melt versus an enuresis alarm.
Materials and methods:. This study included 56 children with primary MNE who were taking desmopressin melt or using an alarm. Their anxiety levels were evaluated using the Social Anxiety Scale for Children-Revised. For both treatment methods, data from a 3-month bedwetting diary between the third and sixth months of the pre-pandemic treatment were compared with those assessed during the same period during the pandemic.
Results:. Prior to the COVID-19 pandemic, the median 3-month mean frequency of MNE was 1 (0–7.67) in children using desmopressin melt versus 1.33 (0–6) in those using alarm treatment (p = 0.095). During the COVID-19 pandemic period, the median monthly mean frequency of MNE was 1.33 (0–7.33) in children using desmopressin melt versus 6 (1.33–13) in those using alarm treatment (p < 0.001).
Conclusions:. The COVID-19 pandemic and its accompanying psychological effects did not affect the treatment efficacy of desmopressin melt in children with primary MNE but did adversely affect that of enuresis alarms. |
| first_indexed | 2024-04-11T04:58:56Z |
| format | Article |
| id | doaj.art-9416b51b1fde4ce185f173a41f237f87 |
| institution | Directory Open Access Journal |
| issn | 1661-7649 1661-7657 |
| language | English |
| last_indexed | 2024-04-11T04:58:56Z |
| publishDate | 2022-06-01 |
| publisher | Wolters Kluwer Health |
| record_format | Article |
| series | Current Urology |
| spelling | doaj.art-9416b51b1fde4ce185f173a41f237f872022-12-26T06:01:49ZengWolters Kluwer HealthCurrent Urology1661-76491661-76572022-06-01162707310.1097/CU9.0000000000000126202206000-00004Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19)Umut UnalHakan AnilMehmet Eflatun DenizEdiz VuruskanAdem AltunkolHakan ErcilAbstract. Objectives:. This study aimed to investigate the effect of the coronavirus disease 2019 (COVID-19) pandemic on the treatment of children with primary monosymptomatic nocturnal enuresis (MNE) with desmopressin melt versus an enuresis alarm. Materials and methods:. This study included 56 children with primary MNE who were taking desmopressin melt or using an alarm. Their anxiety levels were evaluated using the Social Anxiety Scale for Children-Revised. For both treatment methods, data from a 3-month bedwetting diary between the third and sixth months of the pre-pandemic treatment were compared with those assessed during the same period during the pandemic. Results:. Prior to the COVID-19 pandemic, the median 3-month mean frequency of MNE was 1 (0–7.67) in children using desmopressin melt versus 1.33 (0–6) in those using alarm treatment (p = 0.095). During the COVID-19 pandemic period, the median monthly mean frequency of MNE was 1.33 (0–7.33) in children using desmopressin melt versus 6 (1.33–13) in those using alarm treatment (p < 0.001). Conclusions:. The COVID-19 pandemic and its accompanying psychological effects did not affect the treatment efficacy of desmopressin melt in children with primary MNE but did adversely affect that of enuresis alarms.http://journals.lww.com/10.1097/CU9.0000000000000126 |
| spellingShingle | Umut Unal Hakan Anil Mehmet Eflatun Deniz Ediz Vuruskan Adem Altunkol Hakan Ercil Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19) Current Urology |
| title | Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19) |
| title_full | Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19) |
| title_fullStr | Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19) |
| title_full_unstemmed | Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19) |
| title_short | Better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 (COVID-19) |
| title_sort | better outcomes with desmopressin melt than enuretic alarm therapy in children with nocturnal enuresis during coronavirus disease 2019 covid 19 |
| url | http://journals.lww.com/10.1097/CU9.0000000000000126 |
| work_keys_str_mv | AT umutunal betteroutcomeswithdesmopressinmeltthanenureticalarmtherapyinchildrenwithnocturnalenuresisduringcoronavirusdisease2019covid19 AT hakananil betteroutcomeswithdesmopressinmeltthanenureticalarmtherapyinchildrenwithnocturnalenuresisduringcoronavirusdisease2019covid19 AT mehmeteflatundeniz betteroutcomeswithdesmopressinmeltthanenureticalarmtherapyinchildrenwithnocturnalenuresisduringcoronavirusdisease2019covid19 AT edizvuruskan betteroutcomeswithdesmopressinmeltthanenureticalarmtherapyinchildrenwithnocturnalenuresisduringcoronavirusdisease2019covid19 AT ademaltunkol betteroutcomeswithdesmopressinmeltthanenureticalarmtherapyinchildrenwithnocturnalenuresisduringcoronavirusdisease2019covid19 AT hakanercil betteroutcomeswithdesmopressinmeltthanenureticalarmtherapyinchildrenwithnocturnalenuresisduringcoronavirusdisease2019covid19 |